The Massachusetts-based biotech startup incubated at MIT and seed-funded in 2019 approached Seven Elm to conceptualize and execute a logo and identity system from scratch, along with a website capable of relaying its mission in a clear, engaging way to both layperson and industry audiences. We called on a mix of original photography and graphics, and provided a thorough copy-edit, to produce a site that helped simplify Javelin’s patented drug discovery platform without losing any of its impact. The site launch was timed to coincide with Javelin’s 2020 collaboration announcement with Pfizer.